1. Home
  2. DEO vs HLN Comparison

DEO vs HLN Comparison

Compare DEO & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DEO

Diageo plc

HOLD

Current Price

$80.43

Market Cap

44.1B

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.12

Market Cap

41.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEO
HLN
Founded
1886
2022
Country
United Kingdom
United Kingdom
Employees
29860
24524
Industry
Beverages (Production/Distribution)
Package Goods/Cosmetics
Sector
Consumer Staples
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
44.1B
41.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DEO
HLN
Price
$80.43
$9.12
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$109.00
N/A
AVG Volume (30 Days)
1.1M
9.0M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
4.18%
1.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.65
$6.55
Revenue Next Year
N/A
$4.42
P/E Ratio
$90.04
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$72.45
$8.65
52 Week High
$116.41
$11.28

Technical Indicators

Market Signals
Indicator
DEO
HLN
Relative Strength Index (RSI) 45.85 48.07
Support Level $79.98 $9.04
Resistance Level $82.78 $9.44
Average True Range (ATR) 1.41 0.12
MACD -0.72 0.00
Stochastic Oscillator 19.86 63.27

Price Performance

Historical Comparison
DEO
HLN

About DEO Diageo plc

Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: